Delving into the Latest Updates on Actimis Pharmaceuticals, Inc. with Synapse

Overview

Author: Madden, M. ; Tanaka, T. ; Gant, T. G. ; Patel, N. M. ; Ishige, T. ; Kikuchi, K. ; Nair, R. ; Sprague, V. M. ; Mizoguchi, R. ; Orr, R. K. ; Cheng, G. ; Waykole, L. M. ; Deo, K. ; Tamboli, A. A. H. ; Li, S. ; Panandikar, A. M. ; Yurkovski, S. ; Zhou, Y. ; Wang, L. ; Kuroda, A. ; Srinivas, P. V. ; Zhang, C. ; Motoyama, T. ; Cartigny, Y. ; Metsger, L. ; Shahbaz, M. M. ; Sohani, S. V. ; Shukla, B. S. ; Khochikar, P. G. A. ; Graham, P. B. ; Wong, M. ; Sarshar, S. ; Ding, J. G. ; Zheng, Z. ; Dodd, S. K. ; Fu, X. ; Davidson, J. P. ; Sata, K. ; Sun, P. ; Anegondi, S. P. ; Minoguchi, M. ; Suzuki, N. ; Berkenbusch, T. ; Busacca, C. A. ; Xiao, J. ; Ly, T. W. ; Hurley, F. ; Yuan, K. ; Horiuchi, H. ; Loughman, T. C. ; Kothari, H. M. ; Rajmahendra, S. ; Wu, R. ; Sakamoto, K. ; Werne, G. ; Amharar, Y. ; Shimizu, M. ; Kelkar, R. S. ; Jaeger, B. V. R. J. ; Zhang, F. ; Cui, H. ; Dave, M. G. ; Lin, Q. ; Panchasara, D. ; Rivera, V. C. I. ; Hsiao, T. Y. ; Xie, Y. ; Miyata, H. ; Wu, G. G. ; Martin, M. ; Castellanos, L. P. ; Sekiguchi, S. ; Takeguchi, K. ; Cui, J. ; Prasad, A. ; Descamps, G. ; Coquerel, G. ; Ponnusamy, T. ; Zeng, L. ; Chen, Y. ; Ono, S. ; De La, Cruz M. ; Pandey, B. ; Zhang, B. ; Zhong, W. ; Pang, F. ; Johnson, S. R. ; Kulkarni, R. S. ; Chen, F. X. ; Vyas, K. D. ; Dong, Z. X. ; Bajwa, J. S. ; Mittelman, A. ; Silverman, I. R. ; Xie, J. ; Zupancic, S.

The following comments are drawn from recent issues of the weekly Current Patents Gazette, which is based primarily on front-page information from newly published patents and applications.The cases selected are from the Current Patents Gazette section dealing with chem. processes.Many of the cases concerned with conventional process development relate to compounds with com. potential, while combinatorial technol. is generally claimed in the context of more fundamental discovery programs.

100 Deals associated with Actimis Pharmaceuticals, Inc.

Login to view more data

100 Translational Medicine associated with Actimis Pharmaceuticals, Inc.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 10 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Other

1

Login to view more data